• About
    • General information
    • Mission and values
    • History
    • Management
    • Cooperation
  • Production
    • Quality Management System
    • Production capacities
    • Manufacturing capabilities
  • Innovation
    • Avexima R&D Center
    • Departments
    • Technological Equipment
    • Analytical Equipment
  • Medicines
  • Press center
    • News
    • Press kit
  • Career
    • career
  • Contacts
  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
back
  • News
  • Press kit

CARING FOR HEALTH - CREATING THE FUTURE!

News

Results of the Annual General Meeting of Shareholders of JSC Irbit Chemical Pharmaceutical Plant. Change of the enterprise's General Director

21 June 2024

Results of the Annual General Meeting of Shareholders of JSC Irbit Chemical Pharmaceutical Plant. Change of the enterprise's General Director

«SPRING 2024»: first event for residents of the Yesipovo industrial park

25 April 2024

«SPRING 2024»: first event for residents of the Yesipovo industrial park

Avexima participates in «CPhI India 2023»

4 December 2023

Avexima participates in «CPhI India 2023»

Ivan Khalepo appointed as General Director of Pharmaceutical Company Avexima

2 October 2023

Ivan Khalepo appointed as General Director of Pharmaceutical Company Avexima

Avexima at the Russian-Chinese Pharmaceutical Forum

20 June 2023

Avexima at the Russian-Chinese Pharmaceutical Forum

JSC Avexima supports young scientists

14 April 2023

JSC Avexima supports young scientists

  • 3
  • 4
  • 5
  • 6
  • 7

Shown 30 from 68 news

Press kit

Logos

Avexima logo Avexima logo (png 45.11 Kb)

Documents

Company information Company information (pdf 237.54 Kb)

© 2011—2026 JSC Avexima.
All rights of the website are reserved

Personal Data Processing Policy

Avexima invites pharmaceutical distributors and pharmacy chains to cooperate. We will be happy to answer all your questions by phone or e-mail:

  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
  • LENINGRADSKY PR., BLD. 1, MOSCOW, 125284

Applicant's profile

Desired Area *

Attach your resume
Maximum file size 5 MB

Provide information on the safety of the drug (for the patient)

1000

stage 1/5

Report
an undesirable reaction

Sender Information

Patient Information

Information about the suspected drug

Description of the event related to the safety and efficacy of the drug

Additional information

Gestation period in weeks
years
  • years
  • month
  • days
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 1000
Characters left: 300
Characters left: 300
Characters left: 300

Criteria for the severity of an adverse reaction

Outcome

Characters left: 1000
Characters left: 500

Attach files (for example, test results, discharge, doctor's report, etc.) Files should not be larger than 5 MB

Medical Information Request Form

You

Preferred way to receive a response

Leave a request about the quality of the drug

The person reporting a problem with the quality of the medicinal product
Information about the medicinal product and the essence of the treatment

Photos showing a problem with the quality of the drug, including photos with the batch number of the drug

The website uses cookies to personalize user services. By continuing to use the website, you agree to the Cookie Policy and consent to the processing of personal data by Avexima OJSC (31a Leningradsky Ave., building 1, 125284, Moscow). You can disable the storage of cookies in your browser settings.

accept and close